1. Home
  2. ETO vs BWAY Comparison

ETO vs BWAY Comparison

Compare ETO & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Tax-Advantage Global Dividend Opp

ETO

Eaton Vance Tax-Advantage Global Dividend Opp

N/A

Current Price

$28.43

Market Cap

471.2M

Sector

Finance

ML Signal

N/A

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

N/A

Current Price

$13.77

Market Cap

450.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ETO
BWAY
Founded
N/A
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
471.2M
450.8M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
ETO
BWAY
Price
$28.43
$13.77
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.25
AVG Volume (30 Days)
29.5K
91.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$314.08
Revenue Next Year
N/A
$23.37
P/E Ratio
N/A
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$20.05
$7.84
52 Week High
$31.11
$26.63

Technical Indicators

Market Signals
Indicator
ETO
BWAY
Relative Strength Index (RSI) 30.58 30.17
Support Level $28.04 $11.55
Resistance Level $28.77 $17.20
Average True Range (ATR) 0.51 1.13
MACD -0.20 -1.20
Stochastic Oscillator 18.28 16.10

Price Performance

Historical Comparison
ETO
BWAY

About ETO Eaton Vance Tax-Advantage Global Dividend Opp

Eaton Vance Tax-advtgd Global Divid Oppo is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. The portfolio of investments consists of capital markets, chemicals, diversified, beverages, banks, electric utilities, oil, gas and consumable fuels, personal products, and other areas.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: